our commitment is to improve lives by leveraging our cutting-edge technology to create innovative diagnostics.
sqi diagnostics, inc. (tsx-v: sqd; otcqb: sqidf) is a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare providers, patients, and consumers worldwide. the company’s proprietary advanced diagnostics target organ transplant, autoimmune disease and covid-19 testing which include the developmental direct-to-consumer covid-19 home antibody test, the rali-dx™ covid-19 severity triage test and the covid-19 rali-fast™ severity triage point-of-care (poc) test.